Practice Locations

UCHealth Rheumatology Clinic - Anschutz Medical Campus
1635 Aurora Ct 4th Floor, Aurora, CO 80045

720-848-7700

Kevin Deane, MD

Rheumatology

Board Certified

Locations

Practice Locations

UCHealth Rheumatology Clinic - Anschutz Medical Campus
1635 Aurora Ct, 4th Floor
Aurora, CO 80045

720-848-7700

Get directions

Provider Expertise

Clinical Interest for Patients

I am interested in the management of a wide-variety of autoimmune diseases including rheumatoid arthritis and lupus.


Specialties

  • Rheumatology ( 2004 )
  • Internal Medicine ( 2001 )

Education & Training

Medical Schools

MD, Loma Linda University School of Medicine (1997)


Undergraduate Schools

BA, University of California–Davis (CA) (1997)


Graduate Schools

PhD, University of Colorado Denver (2011)


Internships

University of Colorado (1998)


Residency Program

University of Colorado (University Hospital) Program (2000)


Fellowships

University of Colorado (2004)

Professional Memberships

American College of Rheumatology, Member


Research & Grants

Research Interests for Patients

Much of my research is focused on learning how we can identify individuals who are at risk of getting autoimmune disease before they are sick, and then prevent that disease from developing. In particular, I am the lead investigator on a trial in the USA called ‘StopRA’ where we identify people at-risk for future RA through a blood test, and then investigate whether treating them with a drug can delay or prevent future disease. You can learn more about this study as well as my other research in rheumatoid arthritis and other autoimmune diseases by visiting www.stop-ra.org or calling (303) 724-8330.

information for referring providers

Referral Contact Phone

720-848-7700

Clinical Interests for Referring Providers

Rheumatoid Arthritis, Vasculitis, Crystalline Arthropathies

Research Interest for Referring Providers

I am the principal investigator on an NIH-sponsored trial called 'StopRA' that is investigating the ability of the drug hydroxychloroquine (Plaquenil) to prevent or delay the future development of rheumatoid arthritis (RA) in high-risk individuals. In addition, I have numerous other research studies investigating how lung disease may develop in patients with established RA, as well as how synovial biopsies may help identify new targets for RA treatment. Please visit www.stop-ra.org to learn more about my RA prevention studies. In addition, you can reach out to me directly through email at kevin.deane@ucdenver.edu if you have a patient you think could be a candidate for a research study.